Cargando…
Autologous Bone Marrow Transplantation in Multiple Sclerosis: Biomarker Relevance for Patient Recruitment and Follow up
BACKGROUND: Despite the current availability of disease modifying therapies for the treatment of multiple sclerosis, there are still patients who suffer from severe neurological dysfunction in the relapsing-remitting or early progressive forms of the disease. For these patients autologous hematopoie...
Autores principales: | Londoño, Ana C., Mora, Carlos A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5226132/ https://www.ncbi.nlm.nih.gov/pubmed/28090375 http://dx.doi.org/10.4172/2155-9899.1000455 |
Ejemplares similares
-
Nonconventional MRI biomarkers for in vivo monitoring of pathogenesis in multiple sclerosis
por: Londoño, Ana C., et al.
Publicado: (2014) -
Autologous Bone Marrow Derived Stem Cells for the Treatment of Multiple Sclerosis
por: Chahine, Nassim Abi, et al.
Publicado: (2016) -
Multiple Eruptive Eccrine Poromas Associated with Chemotherapy and Autologous Bone Marrow Transplantation
por: Valdebran, Manuel A., et al.
Publicado: (2018) -
Autologous Pancreatic Islet Transplantation in Human Bone Marrow
por: Maffi, Paola, et al.
Publicado: (2013) -
Coronavirus Pneumonia Following Autologous Bone Marrow Transplantation for Breast Cancer
por: Folz, Rodney J., et al.
Publicado: (1999)